Biofil Chemicals & Pharmaceuticals News

Biofil Chemicals Declares Non-Applicability of SEBI

Biofil Chemicals and Pharmaceuticals Limited confirms it does not fall under Large Corporate category as on March 31, 2026, making SEBI debt securities circular non-applicable with outstanding borrowing of ₹0.02 crore.

Biofil Chemicals Publishes Newspaper Notice for SEBI Special Window

Biofil Chemicals published newspaper notices in Free Press Indore and Choutha Sansar on April 3, 2026, informing shareholders about SEBI's special window facility for transfer and dematerialization of physical securities.

Biofil Chemicals Announces SEBI Special Window for Physical Securities

Biofil Chemicals informs shareholders about SEBI's special window for transfer and dematerialization of physical securities sold/purchased before April 2019, available from February 5, 2026 to February 4, 2027.

Biofil Chemicals Submits Q4 FY26 Compliance Certificate

Biofil Chemicals and Pharmaceuticals Limited submitted its quarterly confirmation certificate under SEBI Depositories Regulations for the quarter ended 31st March, 2026, ensuring compliance with dematerialization requirements.

Biofil Chemicals Publishes Q3 FY25 Financial Results

Biofil Chemicals and Pharmaceuticals Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025 in newspapers as per SEBI regulations.